GeneCentric Therapeutics, Inc.

Biotechnology company · Durham, North Carolina, United States

GeneCentric Therapeutics, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

GeneCentric Therapeutics at a glance

Typebiotechnology company

HeadquartersDurham, North Carolina, United States

Earliest incorporation on record2011

SEC CIK1529224

What does GeneCentric Therapeutics do?

Private fundraising reported to the SEC

8 Form D notices; the most recent reported $2 million sold (2025).

Frequently asked questions about GeneCentric Therapeutics

Where is GeneCentric Therapeutics headquartered?

GeneCentric Therapeutics, Inc. is headquartered in Durham, North Carolina, United States.

What does GeneCentric Therapeutics do?

GeneCentric Therapeutics, Inc. is a biotechnology company.

When was GeneCentric Therapeutics founded?

The earliest incorporation on record for GeneCentric Therapeutics, Inc. is in 2011, according to public company registers.

Similar companies

Humacyte, Inc.Durham, North Carolina, United States
Precision Biosciences IncDurham, North Carolina, United States
Xilis, Inc.Durham, North Carolina, United States
inSoma Bio, Inc.Durham, North Carolina, United States
Atsena Therapeutics, Inc.Durham, North Carolina, United States
Scion Neurostim, Inc.Durham, North Carolina, United States
Sapere Bio, Inc.Durham, North Carolina, United States
BioAesthetics CorpDurham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences